Abstract:We report on using the synthetic aminoadamantane-CH2-aryl derivatives 1–6 as sensitive probes for blocking M2 S31N and influenza A virus (IAV) M2 wild-type (WT) channels as well as virus replication in cell culture. The binding kinetics measured using electrophysiology (EP) for M2 S31N channel are very dependent on the length between the adamantane moiety and the first ring of the aryl headgroup realized in 2 and 3 and the girth and length of the adamantane adduct realized in 4 and 5. Study of 1–6 shows that, according to molecular dynamics (MD) simulations and molecular mechanics Poisson–Boltzmann surface area (MM/PBSA) calculations, all bind in the M2 S31N channel with the adamantyl group positioned between V27 and G34 and the aryl group projecting out of the channel with the phenyl (or isoxazole in 6) embedded in the V27 cluster. In this outward binding configuration, an elongation of the ligand by only one methylene in rimantadine 2 or using diamantane or triamantane instead of adamantane in 4 and 5, respectively, causes incomplete entry and facilitates exit, abolishing effective block compared to the amantadine derivatives 1 and 6. In the active M2 S31N blockers 1 and 6, the phenyl and isoxazolyl head groups achieve a deeper binding position and high kon/low koff and high kon/high koff rate constants, compared to inactive 2–5, which have much lower kon and higher koff. Compounds 1–5 block the M2 WT channel by binding in the longer area from V27–H37, in the inward orientation, with high kon and low koff rate constants. Infection of cell cultures by influenza virus containing M2 WT or M2 S31N is inhibited by 1–5 or 1–4 and 6, respectively. While 1 and 6 block infection through the M2 block mechanism in the S31N variant, 2–4 may block M2 S31N virus replication in cell culture through the lysosomotropic effect, just as chloroquine is thought to inhibit SARS-CoV-2 infection.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00553?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00553</a>.Methods (for electrophysiology, anti-viral testing, simulations, and synthetic procedures including the characterization of compounds 1−5), EP results for 1 against the S31 channels of A/Calif/07/2009 M2 N31S and A/Udorn/72 M2 WT, RMSDs from MD simulations, molecular docking and MM-PBSA, SMD calculation results (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00553/suppl_file/cb0c00553_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Front Cover: A Study of the Activity of Adamantyl Amines against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple Blocker, Explored by Molecular Dynamics Simulations and Solid‐State NMR (ChemMedChem 16/2023)

Adamantyl Amines Activity Study Against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple blocker Explored with MD simulations and Solid state NMR

Chemical Probes for Blocking of Influenza A M2 Wild-type and S31N Channels

Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.

Amantadine Variants Activity Against Multiple Influenza A Viruses

Antiviral Mechanisms and Preclinical Evaluation of Amantadine Analogs that Continue to Inhibit Influenza A Viruses with M2 -Based Drug Resistance

Front Cover: Optimization of Ketobenzothiazole‐Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus Replication (ChemMedChem 2/2024)

Structural Basis for Interactions between Influenza A Virus M2 Proton Channel and Adamantane-Based Antiviral Drugs

Virtual Screening and Molecular Growth Guide the Design of Inhibitors for the Influenza Virus Drug-Resistant Mutant M2-V27A/S31N.

Potent Anti-Influenza Synergistic Activity of Theobromine and Arainosine

Mapping Water Density To Design New Blockers Against A Viral Proton Channel

Tackling influenza a virus by M2 ion channel blockers: Latest progress and limitations

Rational design of a deuterium-containing M2-S31N channel blocker UAWJ280 with in vivo antiviral efficacy against both oseltamivir sensitive and -resistant influenza A viruses

Seeing double: the persistent dimer-of-dimers structure of drug resistant influenza A M2

Mechanism of drug inhibition and drug resistance of influenza A M2 channel

Design and synthesis of pinane oxime derivatives as novel anti-influenza agents

Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus

Residue-based Design of Small Molecule Inhibitor for H1N1, H5N1 and H7N1 Mutants

Design, synthesis, and biological activity of a novel series of 2-ureidonicotinamide derivatives against influenza A virus

An effective molecular blocker of ion channel of M2 protein as anti-influenza a drug

Molecular Dynamics Analysis of Potent Inhibitors of M2 Proton Channel Against H1N1 Swine Influenza Virus